Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVAG Study - Covid-19 Antigen Study

NCT05074017 is registered in ClinicalTrials.gov with Synlab Holding Deutschland GmbH as lead sponsor.

NCT NCT05074017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05074017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVAG Study - Covid-19 Antigen Study
Lead sponsor
Synlab Holding Deutschland GmbH
Phase
Observational
Overall status
Completed
Start date
February 1, 2021
Completion date
March 31, 2021
Enrollment
2,222 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars (disease), sars-cov2 infection